FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001066017 Concept inactivation indicator attribute value reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001067014 Concept inactivation indicator reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001068016 Concept inactivation indicator attribute value reference set (foundation metadata concept) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


140498 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Concept inactivation indicator reference set Is a Attribute value type true Inferred relationship Some

Members valueId
benzocain 1 mg halsspray A component that fails to comply with the current editorial guidance.
Benzocaine 20% gel A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
benzocain 20 % salve A component that fails to comply with the current editorial guidance.
benzocain 20 % øredråber A component that is no longer current, useful, appropriate or acceptable.
kombinationspræparat med benzocain 100 mg sugetablet A component that fails to comply with the current editorial guidance.
Benzocaine compound injection solution BPC vial Moved elsewhere
overdosis af benzocain, uvist med hvilken hensigt A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
forgiftning med benzocain, uvist med hvilken hensigt A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
kombinationspræparat med benzocain 100 mg + menthol 3 mg sugetablet A component that fails to comply with the current editorial guidance.
Benzocaine+salicylamide 2%/5% gel A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzocaine+salicylamide 2%/5% gel A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
benzodiazepinantiepileptikum A component that fails to comply with the current editorial guidance.
Benzodiazepine antiepileptic A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzodiazepine dependence A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
benzodiazepinkerne A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzodiazepine poisoning NOS Limited component (foundation metadata concept)
benzodiazepinsedativum A component that fails to comply with the current editorial guidance.
bivirkning af benzodiazepinsedativum Ambiguous
allergi over for benzodiazepinsedativum Erroneous component (foundation metadata concept)
forgiftning med benzoe- OG/ELLER salicylsyre A component that fails to comply with the current editorial guidance.
Benzoic acid A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzoic acid - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
allergi over for benzoesyre Erroneous component (foundation metadata concept)
benzoen- og salicylsyrer Ambiguous
Benzoesyre og derivater A component that fails to comply with the current editorial guidance.
benzoe- og salicylsyresalve A component that fails to comply with the current editorial guidance.
benzoin- og salicylsyresalve Ambiguous
benzomorphanopioid A component that fails to comply with the current editorial guidance.
Benzonatate 100mg A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzophenone-4 A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzophenone-4 A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzoyl peroxide + clindamycin phosphate Erroneous component (foundation metadata concept)
Benzoyl peroxide + clindamycin phosphate 50mg/10mg gel A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
benzoylperoxid 50 mg + erythromycin 30 mg gel A component that fails to comply with the current editorial guidance.
benzoylperoxid 50 mg + hydrocortison 5 mg lotion A component that fails to comply with the current editorial guidance.
benzoylperoxid 10 % wt/wt + svovl 5 % wt/wt A component that fails to comply with the current editorial guidance.
benzoylperoxid + svovl 5 % wt/wt/2 % wt/wt A component that fails to comply with the current editorial guidance.
Benzoyl peroxide - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
benzoylperoxid 10 % A component that fails to comply with the current editorial guidance.
benzoylperoxid 10 % vandig gel A component that fails to comply with the current editorial guidance.
benzoylperoxid 10 % creme Ambiguous
benzoylperoxid 10 % skyllevæske A component that is no longer current, useful, appropriate or acceptable.
Benzoyl peroxide 2.5% + clindamycin 1.2% topical gel A component that is no longer current, useful, appropriate or acceptable.
benzoylperoxid 2,5 % vandig gel Ambiguous
Benzoyl peroxide 2.5% gel Ambiguous
benzoylperoxid 3 % gel A component that fails to comply with the current editorial guidance.
benzoylperoxid 3 % skyllevæske til topikal anvendelse A component that fails to comply with the current editorial guidance.
benzoylperoxid 4 % gel A component that fails to comply with the current editorial guidance.
benzoylperoxid 4 % lotion A component that fails to comply with the current editorial guidance.
benzoylperoxid 5 % vandig gel A component that fails to comply with the current editorial guidance.
benzoylperoxid 5 % skyllevæske til topikal anvendelse A component that fails to comply with the current editorial guidance.
benzoylperoxid 6 % gel A component that fails to comply with the current editorial guidance.
benzoylperoxid 7 % gel A component that fails to comply with the current editorial guidance.
benzoylperoxid 8 % creme A component that is no longer current, useful, appropriate or acceptable.
Benzoyl peroxide 8% cutaneous cream A component that is no longer current, useful, appropriate or acceptable.
benzoylperoxid 8 % gel A component that fails to comply with the current editorial guidance.
benzoylperoxid 8 % lotion A component that fails to comply with the current editorial guidance.
Benzoyl peroxide [acne] A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzoyl peroxide [antifungal] A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzoyl peroxide [generic additions] A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
benzoylperoxid + miconazolnitrat A component that fails to comply with the current editorial guidance.
benzoylperoxid + kaliumhydroxyquinolinsulfat 5/0,5 % gel-lotion A component that fails to comply with the current editorial guidance.
benzoylmethylecgonin Ambiguous
måling af benzoylmethylecgonin Ambiguous
Benzphetamine hydrochloride 50mg tablet A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
benzquinamid 50 mg injektionsvæske, opløsning, hætteglas A component that is no longer current, useful, appropriate or acceptable.
benzquinamidhydrochlorid A component that fails to comply with the current editorial guidance.
Benzthiazide - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benztropine mesylate A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benztropine mesylate - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
benztropinmesylat 1 mg/ml injektion, ampul a 2 ml A component that fails to comply with the current editorial guidance.
benztropinmesylat 2 mg/2 ml injektion A component that fails to comply with the current editorial guidance.
Benztropine mesylate 2mg/2mL solution A component that fails to comply with the current editorial guidance.
Benzydamine hydrochloride - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
benzydaminhydrochlorid 0,15% oral skyllevæske Ambiguous
Benzydamine product A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzyl alcohol A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzyl alcohol and derivatives A component that fails to comply with the current editorial guidance.
Benzyl benzoate - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzyl benzoate 25% application BP Moved elsewhere
Benzyl penicilloyl-polylysin 0.06mcm/.25mL A component that is no longer current, useful, appropriate or acceptable.
Benzyl penicilloyl-polylysin 0.06mmo injection A component that is no longer current, useful, appropriate or acceptable.
Benzyl penicilloyl-polylysin 0.06mmo/0.25mL injection A component that is no longer current, useful, appropriate or acceptable.
benzylpenicilloyl-polylysin 0,06 mmo/0,25 ml injektionsvæske, opløsning, sprøjte a 0,25 ml A component that is no longer current, useful, appropriate or acceptable.
Benzylisoquinolium compound A component that fails to comply with the current editorial guidance.
Benzylpenicillin sodium - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
benzypyrinium Ambiguous
Bephenium hydroxynaphthoate - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beractant - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
beractant 100 mg til intratracheal anvendelse, suspension, hætteglas a 4 ml A component that is no longer current, useful, appropriate or acceptable.
beractant 200 mg/8 ml suspension Ambiguous
Berardinelli lipodystrophy syndrome Ambiguous
Berberine hydrochloride A component that fails to comply with the current editorial guidance.
Bereavement A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bereavement A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bereavement A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bereavement counselling A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bereavement support A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bereavement support A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bergamasca sheep breed Moved elsewhere
Bergamasco dog breed Moved elsewhere

Start Previous Page 162 of 1405 Next End


Reference Sets

Reference set descriptor

Back to Start